Wockhardt Limited has informed the Exchange regarding a press release dated September 19, 2024, titled "Wockhardt's Investigational Drug, Zaynich (Zidebactam/Cefepime) cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use".